Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004134 (
ataxia
)
15,886
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The related high molecular mass microtubule-associated proteins (MAPs) MAP1A and MAP1B are predominantly expressed in the nervous system and are involved in axon guidance and synaptic function. MAP1B is implicated in fragile X mental retardation, giant axonal neuropathy, and
ataxia
type 1. We report the functional characterization of a novel member of the microtubule-associated protein 1 family, which we termed
MAP1S
(corresponding to sequence data bank entries for
VCY2IP1
and C19ORF5).
MAP1S
contains the three hallmark domains of the microtubule-associated protein 1 family but hardly any additional sequences. It decorates neuronal microtubules and copurifies with tubulin from brain.
MAP1S
is synthesized as a precursor protein that is partially cleaved into heavy and light chains in a tissue-specific manner. Heavy and light chains interact to form the
MAP1S
complex. The light chain binds, bundles, and stabilizes microtubules and binds to actin. The heavy chain appears to regulate light chain activity. In contrast to MAP1A and MAP1B,
MAP1S
is expressed in a wide range of tissues in addition to neurons and represents the non-neuronal counterpart of this cytolinker family.
...
PMID:Microtubule-associated protein 1S, a short and ubiquitously expressed member of the microtubule-associated protein 1 family. 1552 9